Prevention of diseases caused by Staphylococcus aureus using the peptide RIP

Related Experiment Video

Updated: Oct 10, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

N Balaban1, L V Collins, J S Cullor

  • 1Department of Medical Pathology, University of California, Davis 95616, USA. nbalaban@ucdavis.edu

Peptides
|November 10, 2000
PubMed

Insights

The heptapeptide RIP effectively combats Staphylococcus aureus infections across multiple sites and strains. This research shows RIP

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococcus aureus is a significant pathogen responsible for various infections like cellulitis, keratitis, osteomyelitis, septic arthritis, and mastitis.
  • Previous studies indicated the heptapeptide RIP could prevent cellulitis induced by S. aureus strain Smith diffuse in mice.

Purpose of the Study:

  • To evaluate the efficacy of the heptapeptide RIP in reducing pathology and delaying disease onset in diverse models of Staphylococcus aureus infections.
  • To determine if RIP's inhibitory activity is strain-specific and effective across multiple body sites.

Main Methods:

  • Testing RIP's efficacy in rabbit models of keratitis and osteomyelitis against specific S. aureus strains.
  • Assessing RIP's effectiveness in cow models of mastitis against multiple S. aureus strains and environmental infections.
  • Evaluating RIP in mouse models of septic arthritis against a specific S. aureus strain.

Main Results:

  • RIP significantly reduced overall pathology and delayed disease onset in keratitis, osteomyelitis, mastitis, and septic arthritis models.
  • RIP demonstrated efficacy across various S. aureus strains, including S. aureus 8325-4, MS, Newbould 305, AE-1, and LS-1.
  • The peptide was effective following diverse administration routes and doses, indicating broad applicability.

Conclusions:

  • The heptapeptide RIP exhibits non-strain-specific inhibitory activity against Staphylococcus aureus.
  • RIP is a potent inhibitor of bacterial pathology at multiple body sites.
  • These findings strongly support the potential of RIP as a valuable chemotherapeutic agent for treating S. aureus infections.

More Related Videos

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...